What Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Sell
48
PTGX Quote, Financials, Valuation and Earnings
Last price:
$43.37
Seasonality move
:
34.62%
Day range:
$43.27 - $45.23
52-week range:
$27.00 - $60.60
Dividend yield:
0%
P/E ratio:
59.03x
P/S ratio:
13.45x
P/B ratio:
3.98x
Volume:
910.1K
Avg. volume:
1.2M
1-year change:
50.99%
Market cap:
$2.7B
Revenue:
$434.4M
EPS (TTM):
$0.75
PTGX Analysts' Consensus Rating
The 6 analysts providing 12-month price projections for Protagonist Therapeutics shares anticipate an average target of $68.70, ranging from a low estimate of $41.00 to a high estimate of $82.00. This average target implies a growth of 55.18% compared to the current stock price of $44.27.
Consensus Price Target
$68.70
Highest Price Target
$82.00
Lowest Price Target
$41.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 5 | 5 | 5 |
| Hold | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
PTGX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Which Stocks Are Recession-Proof?
Fears of a recession prevailed in Q2 2025 when the…
Is Gartner a Safe Stock to Own?
Gartner (NYSE:IT) is among the world’s largest consulting, research and…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
70
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 44x
Alerts
Buy
57
RGC alert for May 14
Regencell Bioscience Holdings [RGC] is up 11.79% over the past day.
Buy
54
HALO alert for May 14
Halozyme Therapeutics [HALO] is down 4.24% over the past day.
Buy
91
COIN alert for May 14
Coinbase Global [COIN] is up 1.11% over the past day.
